Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;29(1):127-48, viii.
doi: 10.1016/j.ncl.2010.10.002.

Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial

Stanley N Caroff  1 , Irene Hurford, Janice Lybrand, E Cabrina Campbell
Affiliations

Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial

Stanley N Caroff et al. Neurol Clin. 2011 Feb.

Abstract

Drug-induced movement disorders have dramatically declined with the widespread use of second-generation antipsychotics, but remain important in clinical practice and for understanding antipsychotic pharmacology. The diagnosis and management of dystonia, parkinsonism, akathisia, catatonia, neuroleptic malignant syndrome, and tardive dyskinesia are reviewed in relation to the decreased liability of the second-generation antipsychotics contrasted with evidence from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial. Data from the CATIE trial imply that advantages of second-generation antipsychotics in significantly reducing extrapyramidal side effects compared with haloperidol may be diminished when compared with modest doses of lower-potency first-generation drugs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed treatment algorithm for tardive dyskinesia.
See this image and copyright information in PMC

References

    1. Preskorn SH. The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol. J Psychiatr Pract. 2007 Jul;13(4):253–257. - PubMed
    1. Rifkin A. Extrapyramidal side effects: a historical perspective. J Clin Psychiatry. 1987 Sep;48(Suppl):3–6. - PubMed
    1. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry. 1975;31:67–72. - PubMed
    1. Caroff S. The Neuroleptic malignant syndrome. J Clin Psychiatry. 1980;41:79–83. - PubMed
    1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988 Sep;45(9):789–796. - PubMed

Publication types

MeSH terms

Substances